GlassScriptPhysician profile
Qiu Zhong
NPI 1609185990
$2,751.31
in general payments reported to CMS, 2019-2025
11 companies · $89.34 in 2025
The $89.34 reported for 2025 was less than what a typical Pediatric Otolaryngology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $158 · 2020: $144 · 2021: $590 · 2022: $14.57 · 2023: $356 · 2024: $1,399 · 2025: $89.34.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,185 · Food and Beverage: $660.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,184.59 |
| Food and Beverage | $660.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,477.39 | 2022-2025 | Tula, Coblation |
| Inspire Medical Systems, INC. | $745.60 | 2021-2025 | Inspire |
| Acclarent, INC | $151.14 | 2019-2023 | Trudi Nav Cable, Acclarent Aera |
| Optinose US, INC. | $113.45 | 2019 | |
| Abiomed | $74.95 | 2023 | Impella |
| Genzyme Corporation | $55.90 | 2023 | |
| Medtronic, INC. | $46.34 | 2023 | Propel |
| Azurity Pharmaceuticals, INC. | $30.13 | 2023 | Triptodur |
| Travere Therapeutics, INC. | $26.06 | 2019 | |
| Olympus America INC. | $16.87 | 2020 | |
| Masimo Corporation | $13.48 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Qiu Zhong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.